Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results
Joint Authors
Falcão-Reis, Fernando M.
Meira, Jorge
Falcão, Manuel
Pedrosa, Ana Catarina
Pinheiro-Costa, João
Neves Cardoso, Pedro
Pinheiro, Ana Fernanda
Carneiro, Ângela M.
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-6, 6 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-10-19
Country of Publication
Egypt
No. of Pages
6
Main Subjects
Abstract EN
Purpose.
To report the long-term clinical outcomes after switching from intravitreal bevacizumab or ranibizumab to aflibercept therapy in eyes with AMD.
Methods.
Retrospective analysis of changes in BCVA, SD-OCT image, and frequency of injections after 1, 2, and 3 years of follow-up.
Results.
164 eyes were analyzed, 101 eyes switched from bevacizumab (group 1) and 63 from ranibizumab (group 2).
One year after the switch, there was an overall nonsignificant mean decrease of 2 ETDRS letters in BCVA.
Three years after, there was an overall mean decrease of 7 ETDRS letters, which was statistically significant.
A significant improvement in the mean CRT was found at 1, 2, and 3 years.
There was a significant decrease in the mean number of injections per year (7.8 to 6.5, p<0.005) between the first and third year.
Conclusion.
Aflibercept can be useful in the management of refractory neovascular AMD, with a good morphological response.
However, in the long-term, BCVA stabilization was not achieved.
American Psychological Association (APA)
Neves Cardoso, Pedro& Pinheiro, Ana Fernanda& Meira, Jorge& Pedrosa, Ana Catarina& Falcão, Manuel& Pinheiro-Costa, João…[et al.]. 2017. Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results. Journal of Ophthalmology،Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1185228
Modern Language Association (MLA)
Neves Cardoso, Pedro…[et al.]. Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results. Journal of Ophthalmology No. 2017 (2017), pp.1-6.
https://search.emarefa.net/detail/BIM-1185228
American Medical Association (AMA)
Neves Cardoso, Pedro& Pinheiro, Ana Fernanda& Meira, Jorge& Pedrosa, Ana Catarina& Falcão, Manuel& Pinheiro-Costa, João…[et al.]. Switch to Aflibercept in the Treatment of Neovascular AMD: Long-Term Results. Journal of Ophthalmology. 2017. Vol. 2017, no. 2017, pp.1-6.
https://search.emarefa.net/detail/BIM-1185228
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1185228